Drug Shortage Report for MYLAN-NAPROXEN/ESOMEPRAZOLE MR
Report ID | 13528 |
Drug Identification Number | 02443449 |
Brand name | MYLAN-NAPROXEN/ESOMEPRAZOLE MR |
Common or Proper name | NAPROXEN/ESOMEPRAZOLE MR |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | ESOMEPRAZOLE NAPROXEN |
Strength(s) | 20MG 500MG |
Dosage form(s) | TABLET (IMMEDIATE AND DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60BT |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-05-15 |
Actual start date | |
Estimated end date | 2019-05-22 |
Actual end date | 2019-05-22 |
Shortage status | Resolved |
Updated date | 2019-05-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v85 | 2019-05-23 | English | Compare |
v84 | 2019-05-22 | French | Compare |
v83 | 2019-05-22 | English | Compare |
v82 | 2019-05-16 | English | Compare |
v81 | 2019-05-14 | French | Compare |
v80 | 2019-05-14 | English | Compare |
v79 | 2019-05-09 | English | Compare |
v78 | 2019-05-08 | French | Compare |
v77 | 2019-05-08 | English | Compare |
v76 | 2019-05-02 | English | Compare |
v75 | 2019-04-30 | French | Compare |
v74 | 2019-04-30 | English | Compare |
v73 | 2019-04-27 | English | Compare |
v72 | 2019-04-23 | French | Compare |
v71 | 2019-04-23 | English | Compare |
v70 | 2019-04-16 | French | Compare |
v69 | 2019-04-16 | English | Compare |
v68 | 2019-04-10 | French | Compare |
v67 | 2019-04-10 | English | Compare |
v66 | 2019-04-03 | French | Compare |